Cant agree with you more , the raiseing should have been at 45c, this company has a lot to offer they just need a CEO who will promote them not treat them as a private company.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%